Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5S ribosomal RNA pseudogene 48 (RNA5SP48) is a member of the family of 5S ribosomal RNA pseudogenes. Pseudogenes are nonfunctional sequences similar to functional genes, typically arising from duplication or retrotransposition events, and are generally not transcribed or translated into functional products. 5S rRNA pseudogenes are non-coding, lack biological activity, and do not contribute to ribosome function[4][6]. Unlike functional 5S ribosomal RNA, which is essential for ribosomal structure and protein synthesis, pseudogenes such as RNA5SP48 are considered genomic relics and are not themselves biologically significant except as markers in genomic studies. This entity is **not a receptor, enzyme, transporter, or other druggable target**. There is no evidence of its involvement in signal transduction, disease, or drug action[4][6]. RNA5SP48 is primarily cited in genome annotation databases as a non-coding, nonfunctional DNA element. Summary of limitations: RNA5SP48 is improperly classified as a therapeutic or molecular target; it is a **pseudogene**, not a protein, enzyme, or receptor. No direct annotation of function, biological role, or drug interactions exists for this "target," and any such categorization would be incorrect. Where pseudogenes such as this are discussed, it is usually in the context of genomic structure or potential effects on gene regulation, not as therapeutic targets[4][6].
Not applicable.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5S ribosomal RNA pseudogene 48 (RNA5SP48).